NASDAQ:ASNS Arsanis (ASNS) Stock Price, News & Analysis → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free ASNS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.72▼$0.8050-Day Range$3.11▼$3.1152-Week Range$1.15▼$28.69Volume2,463 shsAverage Volume15,066 shsMarket Capitalization$2.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestSocial MediaStock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestSocial Media Get Arsanis alerts: Email Address Ad Insiders ExposedThe Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! About Arsanis Stock (NASDAQ:ASNS)X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.Read More Ad Insiders ExposedThe Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! ASNS Stock News HeadlinesApril 4, 2024 | globenewswire.comActelis Networks and Khushi Communications Partner to Enable Expansion of IoT Networks Throughout IndiaMarch 26, 2024 | globenewswire.comActelis Networks Reports Fiscal Full Year 2023 ResultsApril 25, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.March 12, 2024 | finance.yahoo.comActelis Networks and Netceed Sign Partnership Agreement to Extend Actelis’ Hybrid-Fiber Networking Solutions to Netceed’s North American Customer BaseFebruary 29, 2024 | globenewswire.comActelis Achieves National Institute of Standards and Technology (NIST) Certification for Data Cyber SecurityFebruary 7, 2024 | finance.yahoo.comActelis Networks Announces New $1.5 Million Credit LineFebruary 1, 2024 | finance.yahoo.comActelis Receives Order For City of Napa Intelligent Traffic Management SystemJanuary 16, 2024 | finance.yahoo.comActelis Announces U.S. Department of Defense JITC Labs Approval for Cybersecurity and Interoperability and Approved Products List StatusApril 25, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.December 28, 2023 | finance.yahoo.comActelis Receives Order From Major North American Rail Operator For Management Software And ServicesDecember 20, 2023 | finance.yahoo.comActelis Networks Announces Closing of $1.5 Million Private Placement Priced At-The-Market Under Nasdaq RulesDecember 18, 2023 | finance.yahoo.comActelis Networks Announces $1.5 Million Private Placement Priced At-The-Market Under Nasdaq RulesDecember 14, 2023 | finance.yahoo.comActelis Announces Order Received and Launch of New Last Mile Hybrid-Fiber Multi-Gigabit Broadband Solution For Buildings and IoT ApplicationsDecember 7, 2023 | morningstar.comActelis Networks Inc ASNSDecember 6, 2023 | finance.yahoo.comActelis Receives Order For Networking Of Traffic Management and Safety IoT Applications In The City of Everett, WashingtonNovember 29, 2023 | finance.yahoo.comActelis Receives Order From Major German Energy Provider For Encrypted, Cyber-Hardened, Hybrid-Fiber NetworkingNovember 20, 2023 | finance.yahoo.comActelis Delivers Hybrid-Fiber Networking Solutions to US Naval Base In Asia-PacificNovember 14, 2023 | finance.yahoo.comActelis Networks Reports Third Quarter 2023October 24, 2023 | finance.yahoo.comActelis Launches Unique, Ultra Low Power In-Building Gigabit Connectivity Solution For Instant Service Provisioning of Multi-Tenant UnitsOctober 17, 2023 | finance.yahoo.comActelis Selected and Receives First Order to Provide IoT Networking To European Natural Gas System OperatorSeptember 27, 2023 | finance.yahoo.comActelis Achieves Third Party Validation For FIPS Cyber Protection Standard Required by Government AgenciesAugust 28, 2023 | finance.yahoo.comActelis to Participate at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 26, 2023 | seekingalpha.comASNS Actelis Networks, Inc.August 24, 2023 | finance.yahoo.comActelis Networks Reports Second Quarter 2023August 14, 2023 | finance.yahoo.comU.S. Air Force Selects Actelis for IoT Networking Modernization of a Major Air Force BaseAugust 11, 2023 | investing.comX4 Pharmaceuticals (XFOR) Earnings Dates & ReportsAugust 9, 2023 | finance.yahoo.comActelis Receives Orders for Its Hybrid Copper Networking Solutions To Expedite IoT Modernization of Major Highway and Rail Systems Throughout JapanSee More Headlines Receive ASNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arsanis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/26/2024Today4/25/2024Next Earnings (Estimated)5/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Communications equipment, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:ASNS CUSIPN/A CIK1501697 Webwww.arsanis.com Phone(857) 529-8300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.76) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,290,000.00 Net Margins-112.13% Pretax Margin-112.13% Return on Equity-667.48% Return on Assets-52.43% Debt Debt-to-Equity Ratio13.77 Current Ratio0.86 Quick Ratio0.49 Sales & Book Value Annual Sales$5.61 million Price / Sales0.43 Cash FlowN/A Price / Cash FlowN/A Book Value$0.08 per share Price / Book9.95Miscellaneous Outstanding Shares3,020,000Free Float2,591,000Market Cap$2.40 million OptionableNot Optionable Beta0.79 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesPaula S. RaganPresident, Chief Executive Officer & DirectorAdam S. MostafaChief Financial Officer & TreasurerCeleste DiJohnsonVice President-Clinical OperationsMary DiBiaseVice President-Technical Operations & QualityTarek EbrahimVice President-Medical Affairs & Rare DiseaseKey CompetitorsSCWorxNASDAQ:WORXOblongNYSE:OBLGTaopingNASDAQ:TAOPCemtrexNASDAQ:CETXASAPNASDAQ:WTRHView All CompetitorsInsidersTuvia BarlevSold 2,107 sharesTotal: $6,995.24 ($3.32/share)Israel NivSold 422 sharesTotal: $1,401.04 ($3.32/share)View All Insider Transactions ASNS Stock Analysis - Frequently Asked Questions Are investors shorting Arsanis? Arsanis saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 20,200 shares, a drop of 14.4% from the March 15th total of 23,600 shares. Based on an average daily volume of 35,900 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.8% of the company's shares are short sold. View Arsanis' Short Interest. When is Arsanis' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our ASNS earnings forecast. How were Arsanis' earnings last quarter? Arsanis, Inc. (NASDAQ:ASNS) issued its quarterly earnings data on Tuesday, March, 26th. The company reported ($0.67) earnings per share (EPS) for the quarter. The company had revenue of $1.02 million for the quarter. Arsanis had a negative trailing twelve-month return on equity of 667.48% and a negative net margin of 112.13%. When did Arsanis' stock split? Shares of Arsanis reverse split before market open on Wednesday, April 19th 2023. The 1-10 reverse split was announced on Wednesday, April 19th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Arsanis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Arsanis investors own include Catalyst Pharmaceuticals (CPRX), NxStage Medical (NXTM), Selecta Biosciences (SELB), CDTi Advanced Materials (CDTI), Curis (CRIS), bluebird bio (BLUE), Juno Therapeutics (JUNO), Nektar Therapeutics (NKTR), Tocagen (TOCA). When did Arsanis IPO? Arsanis (ASNS) raised $15 million in an initial public offering (IPO) on Friday, May 13th 2022. The company issued 3,000,000 shares at a price of $4.00-$6.00 per share. Boustead Securities served as the underwriter for the IPO. This page (NASDAQ:ASNS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arsanis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
